ProBEAT is a wearable glucose monitor designed to gather big data about the multitude of factors that affect blood glucose levels. The data is then used for predictive algorithms and artificial intelligence-based feedback to go back to wearers (users).
The Loughborough, UK-based med-tech firm plans to launch the proBEAT app in the USA later this year.
READ: Nemaura Medical evaluates new applications for continuous lactate monitoring using its BEAT platform
"The inclusion of data from third-party wearable fitness devices is a significant development and expected to enable the relationship between various activities and factors affecting blood glucose levels to be compared side by side, thus further empowering and educating users of the proBEAT device and app in due course," said Nemaura in a brief statement on Thursday.
Nemaura is advancing micro-systems-based wearable diagnostic devices and is currently commercializing sugarBEAT, which is a non-invasive and flexible continuous glucose monitor (CGM), which may help people with diabetes and pre-diabetes to better manage, reverse and prevent the disease.
ProBEAT comprises a non-invasive glucose monitor and a digital healthcare subscription service and is due to be launched in the US as a general wellness product.
Contact the author at email@example.com